Technology Platforms
PolyXen
polyxen

Enhanced performance of peptide and protein drugs using polysialylation.

More about PolyXen

ImuXen
imuxen

Smart vaccines enabled by liposomal delivery.

More about ImuXen

Product Pipeline

Xenetic is developing a biopharmaceutical pipeline with a multi-billion dollar market potential.

View our product candidates

Share Price
Our Partnerships

Xenetic proactively pursues partnerships with biotechnology and pharmaceutical companies

More about the projects with some of our partners

Latest RNS News

10/05/2013

Commencement of Phase II with MyeloXenT

09/05/2013

Commencement of dosing in Phase III study

View all news

Events Calendar

14.05.13

BioTrinity 2013: Company Showcase

30.10.12

Xenetic to present at Proactive Investors One2One Investor Forum 2013

View all events